Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| An informational packet regarding shingles and the HZV | Experimental |
| |
| Standard medical care from their primary care physician | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| An informational packet regarding shingles and the HZV was sent to patients identified by the EMR | Other | The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Who Received the Herpes Zoster Vaccine | Six months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email | Difference in vaccination rates between patients sent communications via US postal service (USPS) and those sent communications via electronic patient portal (EPP) | 6 months |
| Amount of Time Required by a Clinical Pharmacist to Manage This Workflow |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stuart J Beatty, PharmD | Ohio State University | Principal Investigator |
| Shelley H Otsuka, PharmD | The Ohio State Univeristy | Study Chair |
| Neeraj H Tayal, MD | Ohio State University | Study Chair |
| Kyle Porter, MAS | Ohio State University | Study Chair |
| Peter J Embi, MD, MS | Ohio State University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Ohio State University Martha Morehouse General Internal Medicine Clinic | Columbus | Ohio | 43221 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | An Informational Packet Regarding Shingles and the HZV | An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 6 months |
| FG001 | Standard Medical Care From Their Primary Care Physician |
| COMPLETED |
|
| NOT COMPLETED |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | An Informational Packet Regarding Shingles and the HZV | An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription. |
| BG001 | Standard Medical Care From Their Primary Care Physician | |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants | Participants |
| ||||||||||||||||||
| Age, Continuous | Mean | Standard Deviation | years |
| |||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||||
| Region of Enrollment | Number | participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants Who Received the Herpes Zoster Vaccine | Six months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups. | Posted | Count of Participants | Participants | 6 months |
|
|
| ||||||||||||||||||||||||||||||
| Secondary | Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email | Difference in vaccination rates between patients sent communications via US postal service (USPS) and those sent communications via electronic patient portal (EPP) | Not Posted | 6 months | Participants | ||||||||||||||||||||||||||||||||||
| Secondary | Amount of Time Required by a Clinical Pharmacist to Manage This Workflow | Not Posted | 6 months | Participants |
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | An Informational Packet Regarding Shingles and the HZV | An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription. | 0 | 500 | 0 | 500 | ||
| EG001 | Standard Medical Care From Their Primary Care Physician | 0 | 2,089 | 0 | 2,089 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Stuart Beatty | The Ohio State University College of Pharmacy | 6146888466 | beatty.52@osu.edu |
| ID | Term |
|---|---|
| D002644 | Chickenpox |
| ID | Term |
|---|---|
| D000073618 | Varicella Zoster Virus Infection |
| D006566 | Herpesviridae Infections |
| D004266 | DNA Virus Infections |
| D014777 | Virus Diseases |
| D007239 | Infections |
Not provided
Not provided
| >=65 years |
|
| Male |
|